Quarterly report pursuant to Section 13 or 15(d)

NON CONTROLLING INTEREST

v3.8.0.1
NON CONTROLLING INTEREST
9 Months Ended
Sep. 30, 2017
Notes to Financial Statements  
Note 16 - NON CONTROLLING INTEREST

On July 28, 2016, the Company formed BioCorRx Pharmaceuticals, Inc., a Nevada Corporation, for the purpose of developing certain business lines. In connection with the formation, the, the newly formed sub issued 21.9% ownership to officers of the Company with the Company retaining 78.1%. From inception through September 30, 2017, there were no significant transactions, assets or liabilities in BioCorRx Pharmaceuticals, Inc., or operations since its formation.